Acumen Pharmaceuticals, Inc.
ABOS$159M
Micro CapNASDAQBiological Products, (No Diagnostic Substances)🇺🇸North AmericaNEWTON61 employees
Drugs in Pipeline
1
Phase 3 Programs
0
Upcoming Catalysts
1
Next Catalyst
Oct 15, 2026
28wMarket Overview
Stock performance and key metrics
ABOS News
Catalyst Timeline
1 upcoming, 1 past
Drug Pipeline
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
sabirnetug | Phase 2 | Alzheimer Disease | - | - |
Regulatory Approvals
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply